DI Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
DI Wu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Hui Peng
Department of Endocrine‐metabolic Yichun People's Hospital Yichun China
1 shared publication Mingxia Li
Department of Obstetrics and Gynecology The First Affiliated Center of Chinese People's Liberation Army (PLA) General Hospital Beijing China
1 shared publicationMingyang Wang
Department of Obstetrics and Gynecology The First Affiliated Center of Chinese People's Liberation Army (PLA) General Hospital Beijing China
1 shared publicationXi He
College of Horticulture and Landscape Architecture, Southwest University, Beibei, Chongqing 400715, China
1 shared publicationXianyuan Li
College of Horticulture and Landscape Architecture, Southwest University, Beibei, Chongqing 400715, China
1 shared publication- Yuanguang Meng
School of Medicine Nankai University Tianjin China
1 shared publication
Latest Publications
- Open Access
- 21 February 2025
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 29 (4) , e70316
A Machine Learning Approach to Build and Evaluate a Molecular Prognostic Model for Endometrial Cancer Based on Tumour Microenvironment
Endometrial cancer (EC) incidence and the associated tumour burden have increased globally. To build a molecular expression prognostic model based on the tumour microenvironment to guide personalised treatment using a machine learning approach. Two datasets were reviewed, including a training cohort (n = 698) and a testing cohort (n = 151). All patients underwent hysterectomy ± adnexectomy ± lymph nodes dissection between December 2014 and June 2020 at the PLA General Hospital First Medical Center and received necessary and regular follow‐up. We developed novel models using R software to predict factors that affect survival, such as progression‐free survival and overall survival. Then, the model was optimised by evaluating the prediction efficiency in multiple dimensions. Eight hundred and forty‐nine patients with EC were included in the study. Survival‐related influences on EC patients were identified by univariate analysis and cox regression equations. In addition, a nomogram was visualised in conjunction with demographic characteristics and the above meaningful clinicopathological variables. Ultimately, through a comprehensive assessment, a random forest model (RF16) was developed for complementing the findings of the molecular classification of EC. The RF16 not only specifically characterises tumour molecules, but also enhances the generalizability of the model by replacing gene sequencing with immunohistochemistry. This study showed that the machine learning model (RF16) is low‐cost, efficient, and clinically valuable in guiding treatment for EC patients.
- 21 February 2025
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 29 (4) , e70316
Open AccessA Machine Learning Approach to Build and Evaluate a Molecular Prognostic Model for Endometrial Cancer Based on Tumour Microenvironment
Endometrial cancer (EC) incidence and the associated tumour burden have increased globally. To build a molecular expression prognostic model based on the tumour microenvironment to guide personalised treatment using a machine learning approach. Two datasets were reviewed, including a training cohort (n = 698) and a testing cohort (n = 151). All patients underwent hysterectomy ± adnexectomy ± lymph nodes dissection between December 2014 and June 2020 at the PLA General Hospital First Medical Center and received necessary and regular follow‐up. We developed novel models using R software to predict factors that affect survival, such as progression‐free survival and overall survival. Then, the model was optimised by evaluating the prediction efficiency in multiple dimensions. Eight hundred and forty‐nine patients with EC were included in the study. Survival‐related influences on EC patients were identified by univariate analysis and cox regression equations. In addition, a nomogram was visualised in conjunction with demographic characteristics and the above meaningful clinicopathological variables. Ultimately, through a comprehensive assessment, a random forest model (RF16) was developed for complementing the findings of the molecular classification of EC. The RF16 not only specifically characterises tumour molecules, but also enhances the generalizability of the model by replacing gene sequencing with immunohistochemistry. This study showed that the machine learning model (RF16) is low‐cost, efficient, and clinically valuable in guiding treatment for EC patients.
- 11 June 2019
- Published by Magnolia Press in Phytotaxa
- Vol. 405 (5) , 248-254
Guihaia heterosquama, a new species of coryphoid palm (Arecaceae) from Chongqing, China
Guihaia heterosquama X. Y. Li, a new species from Chongqing, China, is described and illustrated. Guihaia heterosquama is similar to G. grossifibrosa and G. argyrata both in the shape of the leaf blade and flower structure, but it can be easily distinguished by its leaf scales, leaf sheath fibers and hastula. Notably, Guihaia heterosquama differs from all the reported species of Guihaia by the presence of a distinct pistillode in the male flower.
- 11 June 2019
- Published by Magnolia Press in Phytotaxa
- Vol. 405 (5) , 248-254
Guihaia heterosquama, a new species of coryphoid palm (Arecaceae) from Chongqing, China
Guihaia heterosquama X. Y. Li, a new species from Chongqing, China, is described and illustrated. Guihaia heterosquama is similar to G. grossifibrosa and G. argyrata both in the shape of the leaf blade and flower structure, but it can be easily distinguished by its leaf scales, leaf sheath fibers and hastula. Notably, Guihaia heterosquama differs from all the reported species of Guihaia by the presence of a distinct pistillode in the male flower.